Ea. Gill et al., BACTERIAL LIPOPOLYSACCHARIDE INDUCES ENDOTHELIAL-CELLS TO SYNTHESIZE A DEGRANULATING FACTOR FOR NEUTROPHILS, The FASEB journal, 12(9), 1998, pp. 673-684
Enzymes and other factors secreted by degranulating neutrophils (polym
orphonuclear leukocytes, PMNs) mediate endothelial injury, thrombosis,
and vascular remodeling. In bacteremia and sepsis syndrome and their
consequent complications (including acute respiratory distress syndrom
e and systemic ischemia-reperfusion resulting from septic shock), neut
rophil degranulation is an important mechanism of injury. In related s
tudies, we found that human endothelial cells regulate neutrophil degr
anulation and that inflammatory cytokines induce synthesis of degranul
ating factors by human endothelial cells. Here we show that lipopolysa
ccharides (LPS) from gram-negative bacteria were the most potent agoni
sts for release of degranulating activity by endothelial cells when co
mpared to several cytokines and stimulatory factors. LPS also induced
the release of degranulating signals for PMNs from a human endothelial
cell line, EA.hy 926. Interleukin 8 (IL-8) is synthesized by endothel
ial and EA.hy 926 cells in response to LPS and induces neutrophil degr
anulation. However, complementary strategies using receptor desensitiz
ation, translation of messenger RNA by Xenopus laevis oocytes, and pur
ification and analysis of factors from conditioned supernatants demons
trated that degranulating factors distinct from IL-8 are generated in
response to LPS. The characteristics of a partially purified degranula
ting factor isolated from conditioned supernatants distinguished it fr
om known chemokines and other factors that induce PMN degranulation an
d are generated by endothelial cells in response to LPS. Thus, culture
d human endothelial cells and endothelial cell lines synthesize severa
l unique signaling molecules that can trigger neutrophil granular secr
etion. If produced in vivo in response to LPS or other pathologic agon
ists, these degranulating signals may activate PMNs in combination or
in sequence, initiating or propagating vascular damage.